Show simple item record

dc.contributor.authorMittal, Seema
dc.contributor.authorCai, Yufeng
dc.contributor.authorNalam, Madhavi N. L.
dc.contributor.authorBolon, Daniel N A
dc.contributor.authorSchiffer, Celia A.
dc.date2022-08-11T08:08:00.000
dc.date.accessioned2022-08-23T15:38:50Z
dc.date.available2022-08-23T15:38:50Z
dc.date.issued2012-03-07
dc.date.submitted2012-10-10
dc.identifier.citation<p>J Am Chem Soc. 2012 Mar 7;134(9):4163-8. Epub 2012 Feb 28. <a href="http://dx.doi.org/10.1021/ja2095766" target="_blank">Link to article on publisher's site</a></p>
dc.identifier.issn0002-7863 (Linking)
dc.identifier.doi10.1021/ja2095766
dc.identifier.pmid22295904
dc.identifier.urihttp://hdl.handle.net/20.500.14038/26023
dc.description.abstractHuman immunodeficiency virus Type-1 (HIV-1) protease is crucial for viral maturation and infectivity. Studies of protease dynamics suggest that the rearrangement of the hydrophobic core is essential for enzyme activity. Many mutations in the hydrophobic core are also associated with drug resistance and may modulate the core flexibility. To test the role of flexibility in protease activity, pairs of cysteines were introduced at the interfaces of flexible regions remote from the active site. Disulfide bond formation was confirmed by crystal structures and by alkylation of free cysteines and mass spectrometry. Oxidized and reduced crystal structures of these variants show the overall structure of the protease is retained. However, cross-linking the cysteines led to drastic loss in enzyme activity, which was regained upon reducing the disulfide cross-links. Molecular dynamics simulations showed that altered dynamics propagated throughout the enzyme from the engineered disulfide. Thus, altered flexibility within the hydrophobic core can modulate HIV-1 protease activity, supporting the hypothesis that drug resistant mutations distal from the active site can alter the balance between substrate turnover and inhibitor binding by modulating enzyme activity.
dc.language.isoen_US
dc.relation<a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=22295904&dopt=Abstract">Link to Article in PubMed</a>
dc.relation.urlhttp://dx.doi.org/10.1021/ja2095766
dc.subjectCrystallography, X-Ray
dc.subjectEnzyme Activation
dc.subjectHIV Protease
dc.subjectHydrophobic and Hydrophilic Interactions
dc.subjectModels, Molecular
dc.subjectMolecular Dynamics Simulation
dc.subjectMutation
dc.subjectProtein Conformation
dc.subjectBiochemistry, Biophysics, and Structural Biology
dc.subjectPharmacology, Toxicology and Environmental Health
dc.titleHydrophobic core flexibility modulates enzyme activity in HIV-1 protease
dc.typeJournal Article
dc.source.journaltitleJournal of the American Chemical Society
dc.source.volume134
dc.source.issue9
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/bmp_pp/152
dc.identifier.contextkey3383247
html.description.abstract<p>Human immunodeficiency virus Type-1 (HIV-1) protease is crucial for viral maturation and infectivity. Studies of protease dynamics suggest that the rearrangement of the hydrophobic core is essential for enzyme activity. Many mutations in the hydrophobic core are also associated with drug resistance and may modulate the core flexibility. To test the role of flexibility in protease activity, pairs of cysteines were introduced at the interfaces of flexible regions remote from the active site. Disulfide bond formation was confirmed by crystal structures and by alkylation of free cysteines and mass spectrometry. Oxidized and reduced crystal structures of these variants show the overall structure of the protease is retained. However, cross-linking the cysteines led to drastic loss in enzyme activity, which was regained upon reducing the disulfide cross-links. Molecular dynamics simulations showed that altered dynamics propagated throughout the enzyme from the engineered disulfide. Thus, altered flexibility within the hydrophobic core can modulate HIV-1 protease activity, supporting the hypothesis that drug resistant mutations distal from the active site can alter the balance between substrate turnover and inhibitor binding by modulating enzyme activity.</p>
dc.identifier.submissionpathbmp_pp/152
dc.contributor.departmentDepartment of Biochemistry and Molecular Pharmacology
dc.source.pages4163-8


This item appears in the following Collection(s)

Show simple item record